Edition:
India

Kalvista Pharmaceuticals Inc (KALV.OQ)

KALV.OQ on NASDAQ Stock Exchange Global Market

9.51USD
15 Dec 2017
Change (% chg)

$0.30 (+3.26%)
Prev Close
$9.21
Open
$9.21
Day's High
$9.76
Day's Low
$9.21
Volume
54,719
Avg. Vol
32,308
52-wk High
$15.75
52-wk Low
$5.48

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Oct 1.13 -0.498
Jul 0.10 -0.507
FY 2017 Apr '17 0.11 -0.440
Jan '17 0.25 -0.998
FY 2016 Sep '16 0.01 -1.268
Jun '16 0.01 -3.907
Mar '16 0.01 -3.513
FY 2015 Dec '15 0.01 -3.205
Sep '15 0.01 -2.654
Jun '15 0.01 -5.191
Mar '15 0.01 -4.760
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jan-18 1 5.40 5.40 5.40 --
Quarter Ending Apr-18 1 5.30 5.30 5.30 --
Year Ending Apr-18 1 12.20 12.20 12.20 --
Year Ending Apr-19 1 14.40 14.40 14.40 --
Earnings (per share)
Quarter Ending Jan-18 1 -0.13 -0.13 -0.13 --
Quarter Ending Apr-18 1 -0.16 -0.16 -0.16 --
Year Ending Apr-18 1 -1.21 -1.21 -1.21 --
Year Ending Apr-19 1 -1.40 -1.40 -1.40 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 31.14 32.93
P/E High - Last 5 Yrs. -- 40.91 45.62
P/E Low - Last 5 Yrs. -- 23.80 24.34
Beta -- 0.90 0.88
Price to Sales (TTM) 151.44 3.93 5.40
Price to Book (MRQ) 2.63 4.81 5.38
Price to Tangible Book (MRQ) 2.63 5.53 6.78
Price to Cash Flow (TTM) -- 23.04 23.45
% Owned Institutions 80.82 0.88 1.40

Dividends

  Company industry sector
Dividend Yield -- 1.56 1.50
Dividend Yield - 5 Year Avg -- 1.57 1.52
Dividend 5 Year Growth Rate -- 4.33 5.17
Payout Ratio(TTM) -- 45.73 43.76

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 1,271.43 3.57 9.00
Sales (TTM) vs TTM 1 Yr. Ago 1,503.45 4.66 5.38
Sales - 5 Yr. Growth Rate -- 10.11 10.33
EPS (MRQ) vs Qtr. 1 Yr. Ago 87.02 16.54 19.67
EPS (TTM) vs TTM 1 Yr. Ago 75.80 -- --
EPS - 5 Yr. Growth Rate -- 9.86 10.79
Capital Spending - 5 Yr. Growth Rate -- 15.30 15.25

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.11 2.18
Current Ratio (MRQ) 7.87 2.88 2.98
LT Debt to Equity (MRQ) 0.80 9.47 11.56
Total Debt to Equity (MRQ) 1.55 13.43 15.81
Interest Coverage (TTM) -29.72 36.29 33.29

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 55.14 54.83
Gross Margin - 5 Yr. Avg. -- 52.29 52.40
EBITD Margin (TTM) -4,520.00 -- --
EBITD - 5 Yr. Avg -- 18.46 15.24
Operating Margin (TTM) -4,529.25 14.50 7.76
Operating Margin - 5 Yr. Avg. -- 14.42 10.75
Pre-Tax Margin (TTM) -4,120.21 14.95 8.57
Pre-Tax Margin - 5 Yr. Avg. -- 14.74 11.17
Net Profit Margin (TTM) -4,120.21 11.22 4.88
Net Profit Margin - 5 Yr. Avg. -- 11.08 7.47
Effective Tax Rate (TTM) -- 23.21 23.11
Effective Tax Rate - 5 Yr. Avg. -- 23.44 24.00

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 953,213,828 864,680,848
Net Income/Employee (TTM) -- 112,151,383 101,718,394
Receivable Turnover (TTM) -- 5.60 5.76
Inventory Turnover (TTM) -- 2.58 3.34
Asset Turnover (TTM) 0.01 0.95 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -55.70 11.42 11.00
Return on Assets - 5 Yr. Avg. -- 13.00 12.43
Return on Investment (TTM) -60.80 14.86 14.46
Return on Investment - 5 Yr. Avg. -- 17.00 16.28
Return on Equity (TTM) -61.05 16.28 16.05
Return on Equity - 5 Yr. Avg. -- 18.03 17.51
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -- -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Kalvista Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 62.71%
# of Holders: 21
Total Shares Held: 6,762,761
3 Mo. Net Change: -1,087,210
# New Positions: 1
# Closed Positions: 4
# Increased Positions: 8
# Reduced Positions: 6
# Net Buyers: 2
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.